OptimizeRx Corp Insider Trading for January 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OptimizeRx Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in OptimizeRx Corp for January 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,315 | 32,406 | 107,134 | |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,315 | 32,406 | 90,217 | 85.9 K to 90.2 K (+5.02 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 47.25 | 5,032 | 237,762 | 85,902 | 90.9 K to 85.9 K (-5.53 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,315 | 32,406 | 107,134 | |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,315 | 32,406 | 90,217 | 85.9 K to 90.2 K (+5.02 %) |
Jan 29 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 47.25 | 5,032 | 237,762 | 85,902 | 90.9 K to 85.9 K (-5.53 %) |
Jan 20 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 802 | 0 | 31,714 | 30.9 K to 31.7 K (+2.59 %) |
Jan 20 2021 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Grant | A | 0.00 | 1,183 | 0 | 30,912 | 29.7 K to 30.9 K (+3.98 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 5,000 | 37,550 | 96,993 | |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 5,000 | 37,550 | 90,937 | 85.9 K to 90.9 K (+5.82 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 5,000 | 37,550 | 96,993 | |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 38.89 | 5,000 | 194,450 | 85,937 | 90.9 K to 85.9 K (-5.50 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 5,000 | 37,550 | 90,937 | 85.9 K to 90.9 K (+5.82 %) |
Jan 15 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 38.89 | 5,000 | 194,450 | 85,937 | 90.9 K to 85.9 K (-5.50 %) |
Jan 11 2021 | OPRX | OptimizeRx Corp | Silvestro Stephen L | CHIEF COMMERCIAL OF ... | Option Exercise | A | 37.50 | 38,511 | 1,444,163 | 144,444 | |
Jan 11 2021 | OPRX | OptimizeRx Corp | Paramore Miriam J | PRESIDENT | Option Exercise | A | 37.50 | 24,093 | 903,488 | 254,318 | |
Jan 11 2021 | OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 28,883 | 0 | 28,883 | |
Jan 11 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | A | 37.50 | 14,456 | 542,100 | 116,449 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,000 | 30,040 | 101,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 4,566 | 11,232 | 105,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,000 | 30,040 | 90,937 | 86.9 K to 90.9 K (+4.60 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 7.51 | 4,000 | 30,040 | 101,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 4,566 | 11,232 | 86,937 | 82.4 K to 86.9 K (+5.54 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Option Exercise | M | 2.46 | 4,566 | 11,232 | 105,993 | |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 32.88 | 8,334 | 274,022 | 82,371 | 90.7 K to 82.4 K (-9.19 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 7.51 | 4,000 | 30,040 | 90,937 | 86.9 K to 90.9 K (+4.60 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Buy | M | 2.46 | 4,566 | 11,232 | 86,937 | 82.4 K to 86.9 K (+5.54 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | BAKER DOUGLAS P | CHIEF FINANCIAL OFF ... | Sell | S | 32.88 | 8,334 | 274,022 | 82,371 | 90.7 K to 82.4 K (-9.19 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | WASSON GREGORY D | Director | Grant | A | 0.00 | 802 | 0 | 16,985 | 16.2 K to 17 K (+4.96 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | WASSON GREGORY D | Director | Grant | A | 0.00 | 1,183 | 0 | 16,183 | 15 K to 16.2 K (+7.89 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | WASSON GREGORY D | Director | Grant | A | 0.00 | 802 | 0 | 16,985 | 16.2 K to 17 K (+4.96 %) |
Jan 05 2021 | OPRX | OptimizeRx Corp | WASSON GREGORY D | Director | Grant | A | 0.00 | 1,183 | 0 | 16,183 | 15 K to 16.2 K (+7.89 %) |